Likarda
PrivateLast Round
Grant
Nov 19, 2025
Total Funding Raised
$4.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Likarda is a biotechnology company that provides a hydrogel-based platform, Core-Shell Spherification® (CSS®), for the encapsulation and delivery of cell therapies, biologics, and small molecules to partner biotech and pharmaceutical companies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Likarda Comparables
Compare Likarda with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lena Biosciences | 77% | |
| Emulate | 75% | |
| Vivodyne | 74% |
For institutional investors. Book with your work email.
Likarda Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2025 | ||||
| Grant | Feb 1, 2025 | ||||
| Grant | Sep 7, 2021 | ||||
| Series A | Nov 7, 2017 |
For institutional investors. Book with your work email.
Likarda Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Werth Family Investment Associates | Series A |
| Bill & Melinda Gates Foundation | Grant |
| BioTools Innovator | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 41% MoM, reaching 2.3K.
- Jan 25, 2026
Monthly visitors increased 41% MoM.
For institutional investors. Book with your work email.
Likarda Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Likarda's valuation, stock price, and market status.
Is Likarda a public or private company?
Likarda is a private company.
What is the current stock price of Likarda?
Likarda is a private company, so its shares have no public market price. Caplight tracks Likarda's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Likarda worth (valuation)?
Valuation information for Likarda is not publicly available.
Can I buy Likarda stock?
Likarda shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Likarda's last funding round?
Likarda's most recent funding round was Grant on November 19, 2025.
Who are the main investors in Likarda?
Key investors in Likarda include Werth Family Investment Associates.
Will Likarda IPO soon?
No public IPO plans have been announced for Likarda.
How can I track Likarda secondary market activity?
Caplight tracks bids, offers, and trades in Likarda's shares on secondary markets.